Clinical Trials in Maryland

Showing 3721-3740 of 11,119 trials

The clonoSEQ® Watch Registry

NCT04545333

This is a prospective, multicenter, observational study of adult patients with a diagnosis of acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), or non-Hodgkin lymphoma (NHL). This study will enroll up to 528 patients in up to 50 sites in the United States and collect data with regard to use of the clonoSEQ MRD assay in the management of lymphoid malignancies.

Acute Lymphoblastic Leukemia, Adult B-CellChronic Lymphocytic LeukemiaMultiple Myeloma+1 more

Adaptive Biotechnologies465 participantsStarted Oct 2020

Stanford, California, United States • Washington D.C., District of Columbia, United States • Fort Lauderdale, Florida, United States +11 more locations

TERMINATEDPhase 1/217 miles

A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors

NCT04408599

This research study is studying a new drug, NC410, as a possible treatment for advanced or metastatic solid tumors.

Advanced or Metastatic Solid TumorsOvarian CancerGastric Cancer+1 more

NextCure, Inc.46 participantsStarted Jun 2020

Bethesda, Maryland, United States • Hackensack, New Jersey, United States • New York, New York, United States +2 more locations

The clonoSEQ® Watch Registry

A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors

Find Trials by Condition in Maryland

Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

A Study of MK-8189 in Participants With Schizophrenia (MK-8189-014)

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Episealer® Knee System IDE Clinical Study

Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation